BOSTON, MA, July 8 2015 — Fuld + Company announced that David Staknis is its new senior vice president and head of the global life sciences practice. David has been with Fuld for more than seven years in both a project manager and director role, and brings a combination of deep life sciences industry experience, strong knowledge of all aspects of Fuld + Company’s services and value, and excellent client relationship management experience.
"David has long been one of our key contributors," said Kenneth Sawka, Fuld + Company CEO and president. "I'm excited to have him in this new leadership role, where his deep life sciences industry knowledge and practical competitive intelligence skills will help him lead this critical practice."
Prior to joining Fuld, Dr. Staknis was a senior analyst and division leader at Global Prior Art, Inc., an intellectual property search and consulting firm, where he worked closely with law firms, biotechnology and pharmaceutical companies. Prior to that, he was a technology transfer specialist at Beth Israel Deaconess Medical Center. He was also a biology instructor at Northeastern University and has fourteen years of bench research experience. Dr. Staknis holds a B.S. in biology from Syracuse University and a Ph.D. in cellular and developmental biology from Harvard University.
Fuld + Company: With 35 years of experience and offices on three continents, Fuld + Company developed many of the competitive intelligence and strategic analysis techniques used today by companies worldwide. Through deep research, penetrating analysis and strategic advisory expertise, our team of professionals helps the Global 1000 identify and solve their tactical and strategic challenges. We have completed thousands of assignments and are recognized as thought leaders, valued advisors, and partners to industry by publications ranging from Fortune, Fast Company, and The Financial Times, to the Economist and Time Magazine.